Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-5.06M |
|
-- |
|
-- |
|
$5.09M |
|
$-5.09M |
|
$0.03M |
|
$-5.06M |
|
$-5.06M |
|
$-5.06M |
|
$-5.06M |
|
$-5.06M |
|
$-5.06M |
|
$-5.09M |
|
$-5.09M |
|
8.05M |
|
8.05M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$5.23M |
|
$0.15M |
|
$0.23M |
|
$5.46M |
|
$1.77M |
|
-- |
|
-- |
|
$1.77M |
|
$3.69M |
|
$3.69M |
|
$3.69M |
|
8.05M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.96 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-137.28% |
|
-137.28% |
|
-92.78% |
|
-137.28% |
|
$0.46 |
|
-- |
|
-- |
|